HSP90AB1 and cancer: Moreover, the HSP90 alpha and beta isoforms are often released with extracellular vesicles (EV), including exosomes, by cancer cells and trigger cancer initiation and progression, as well as the polarization of tumor-associated macrophages (TAM) to an immunosuppressive M2 subtype [6,17,20,21,22].